Tulip Medical Consulting, LLC. is a physician consulting service organization started in October 2010 by Corine de Boer, MD, PhD to provide strategic, logistical and operational clinical research development services to biotechnology and pharmaceutical companies.
Dr. de Boer has more than 20 years experience designing, conducting and analysing a variety of international pre-clinical and phase-1 through phase-4 clinical trials. She has provided support for a variety of vaccines, adjuvants, small molecule/polymeric theraputics and biologics from discovery to launch including commercial support and scientific publications. Prior to launching Tulip Medical Consulting, LLC., Dr. de Boer worked for nearly a decade in the bio-pharmaceutical industry initially at Chiron Corporation and Novartis Vaccines & Diagnostics and most recently as Senior Director, Clinical Development at Dynavax Technologies where she was responsible for their phase-3 Hepatitis B vaccine program in chronic kidney disease patients.
Pediatric Plans (PIP/PSP), Vaccines (Cancer and ID), Adjuvants, Biologics, Infectious Diseases incl Meningococcal Disease, HIV/AIDS and Hepatitis B, Immunology, Nephrology, Dialysis, Kidney Transplantation, Cardiovascular, Metabolic Disorders (PKU, MPS), Orphan Drugs and Rare Disease, and Pediatrics (Oncology, Inborn Metabolic Diseases, Cystic Fibrosis, Gastroenterology).